CS logo
small CS logo
IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II

Padova, Veneto, Italy
Cancer treatment center in Padua
Via Gattamelata, 64, 35128 Padova PD

About IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
31
EMD Serono Research & Development Institute, Inc.
3
Fondazione Ricerca Traslazionale
2
Canadian Cancer Trials Group
1
Genentech, Inc.
1
Gruppo Oncologico Italiano di Ricerca Clinica
1
NCIC Clinical Trials Group
1
University of Bologna
1
Total Rows: 8

Clinical Trials at IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II


During the past decade, IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 13 clinical trials were completed, i.e. on average, 44.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 8 clinical trials were completed. i.e. 53.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11004444557766220000330022222222Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer
2009-09-04
2015-11-27
Completed
720
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
2011-07-01
2017-06-14
Completed
1,232
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
2013-08-19
2017-05-05
Completed
296
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)
2013-07-31
2019-05-28
Completed
159
A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
2013-08-14
2021-01-26
Completed
153
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846

Rows per page:

1–41 of 41

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II" #1 sponsor was "Hoffmann-La Roche" with 31 trials, followed by "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Fondazione Ricerca Traslazionale" with 2 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II" #1 collaborator was "AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations Pathology" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "AOU S. Orsola Malpighi - Clinical Trial Office" with 1 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator and "Bioikos Ambiente Srl" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 31Hoffmann-La Roche: 31EMD Serono Research &Development Institute,Inc.: 3EMD Serono Research &Development Institute,Inc.: 3Fondazione RicercaTraslazionale: 2Fondazione RicercaTraslazionale: 2Canadian Cancer Trials Group: 1Canadian Cancer Trials Group: 1Genentech, Inc.: 1Genentech, Inc.: 1Gruppo OncologicoItaliano di RicercaClinica: 1Gruppo OncologicoItaliano di RicercaClinica: 1NCIC Clinical Trials Group: 1NCIC Clinical Trials Group: 1University of Bologna: 1University of Bologna: 1

Created with Highcharts 11.1.0Top CollaboratorsAOU S.Orsola Malpighi-Unit of OncologicMolecular andTransplantationsPathology: 2AOU S.Orsola Malpighi-Unit of OncologicMolecular andTransplantationsPathology: 2Merck KGaA,Darmstadt, Germany: 2Merck KGaA,Darmstadt, Germany: 2AOU S. Orsola Malpighi- Clinical Trial Office: 1AOU S. Orsola Malpighi- Clinical Trial Office: 1Australasian LungCancer Trials Group: 1Australasian LungCancer Trials Group: 1Bioikos Ambiente Srl: 1Bioikos Ambiente Srl: 1Central and EasternEuropean OncologyGroup: 1Central and EasternEuropean OncologyGroup: 1Chinese ThoracicOncology Group: 1Chinese ThoracicOncology Group: 1Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1Clinical researchtechnology Srl: 1Clinical researchtechnology Srl: 1Dutch Society ofPhysicians forPulmonology andTuberculosis: 1Dutch Society ofPhysicians forPulmonology andTuberculosis: 1

Clinical Trials Conditions at IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II


According to Clinical.Site data, the most researched conditions in "IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II" are "Breast Cancer" (7 trials), "Non-Small Cell Lung Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Head and Neck Neoplasms" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II" in a lesser frequency.

Clinical Trials Intervention Types at IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II


Most popular intervention types in "IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II" are "Drug" (40 trials), "Radiation" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (14 trials), "Placebo" (13 trials), "Paclitaxel" (9 trials), "Carboplatin" (5 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

Clinical Trials Genders at IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II


The vast majority of trials in "IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II" are 40 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II


Currently, there are NaN active trials in "IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II". undefined are not yet recruiting, 12 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 27Phase 3: 27Phase 2: 13Phase 2: 13Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 13Active, not recruiting: 13Completed: 13Completed: 13Recruiting: 12Recruiting: 12Unknown status: 2Unknown status: 2Terminated: 1Terminated: 1